Search

MORE NEWS
HEALTHCARE | Tony Chua, Singapore
Published: 07 Apr 11
1516 views


A*STAR scientists join forces with Servier to develop anti-cancer drugs

The partnership aim to develop drugs restricting the growth of tumor-initiating cells in breast cancer.

A*STAR’s Singapore Immunology Network (SIgN) has inked a Research Collaboration Agreement (RCA) with Servier, the second largest French pharmaceutical company in the world. The collaboration aims to develop anti-cancer drugs to suppress tumor-initiating cells (TICs), often called “cancer stem cells”. By targeting TICs, scientists hope to be able to prevent relapse and metastatic outgrowth in cancer patients.

Under this three-year partnership, SIgN and Servier aim to develop drugs directed at restricting the growth of TICs in breast cancer - the most common cancer in women all over the world, and also in Singapore with about 1,100 new cases diagnosed each year. Scientists at SIgN, with their expertise in tumour immunology and therapeutic antibodies, will be able to isolate TIC-specific human monoclonal antibodies, and with the help of Servier, develop them into anti-cancer drugs, accordinbg to an A*STAR report.

As Associate Professor Jean-Pierre Abastado, Principal Investigator of SIgN that will head the lab for this SIgN-Servier collaboration said, “Scientists and clinicians have been trying to understand why cancer relapse occurs in spite of the removal of the primary tumor. Basic research conducted at SIgN has shown that cancer relapse could potentially be avoided by controlling TICs. Our task at hand is to discover the monoclonal antibodies that will target these TICs.”

Dr. Emmanuel Canet, MD PhD, Head of Research & Development at Servier added, “This partnership exemplifies our vision to collaborate with leading scientists worldwide to discover and develop innovative medicines in the field of cancer where the medical need is still huge. We have been very impressed by the quality of the research work done at the Singapore Immunology Network (SIgN), which we believe is one of the best such institutes in the world.”

“Elimination of tumour initiating cells represents a major challenge in oncology. The aim of this collaboration is to develop an innovative approach to identify membrane neo-antigens specifically expressed by breast cancer stem cells. There is a great therapeutic potential since therapeutic antibodies against these neo-antigens could be used to control the residual disease by eliminating cancer stem cells persisting after conventional therapies", said Dr Stéphane Depil, MD PhD, director of Oncology Research & Development Unit at Servier.”

Prof Paola Castagnoli, Scientific Director of SIgN added “This project is supported by a joint lab between Servier and us and it will be located within SIgN. This is a strategy that we have already successfully developed last year with another company, in the field of Infectious Diseases. Pharma companies are very interested to develop new projects where they can find both an excellent scientific environment, together with unique technology platforms such as our fully human Monoclonal Platform and our Immuno-monitoring platform that can speed up the process of drug discovery.”

Chairman of SIgN, Prof Philippe Kourilsky commented, “I believe that this partnership with Servier will soon lead to the discovery of novel cancer drugs that will effectively control cancer relapse, enhancing the survival of cancer patients. I’m particularly delighted that this work stems from the results of basic research in Tumour Immunology conducted at SIgN. This partnership with Servier was made possible thanks to the powerful human monoclonal antibody platform that we have developed. This is an excellent example of how public research institutes and private companies can leverage on each other’s strength to come up with innovative solutions to address pressing medical needs such as fighting cancer effectively.”



Sign up for our newsletter

 

Do you know more about this story? Contact us anonymously through this link.

Click here to learn about advertising, content sponsorship, events & rountables, custom media solutions, whitepaper writing, sales leads or eDM opportunities with us.

To get a media kit and information on advertising or sponsoring click here.

Tags: A*STAR Servier, A*STAR Servier research, A*STAR Servier cancer drug research

LATEST HEALTHCARE JOBS »
  • No jobs posted on this category.
    PRINT ISSUE »

    Subscribe Now
    What factors are keeping expats rooted in Singapore?

    84 views

    What factors are keeping expats rooted in Singapore?

    311 views

    Can Asian private equity outgrow the west?

    70 views

    MOST READ EXCLUSIVES

    Singapore’s 10 most sought-after 40 and under investors

    Singapore’s 10 most sought-after 40 and under investors

    Check out who made the cut.

    by KRISANA GALLEZO
    19 Dec 2014 | 35408 views
     

    Singapore’s first permanent lifestyle market opens in Bukit Timah

    Singapore’s first permanent lifestyle market opens in Bukit Timah

    Over 20 brands and labels are gathered together under one roof.

    by KRISANA GALLEZO
    5 Jan 2015 | 29539 views

    Singapore’s top 5 work from home jobs

    Singapore’s top 5 work from home jobs

    Here are jobs that you can do while sitting on your couch or in your favorite coffee shop.

    by KRISANA GALLEZO
    11 Dec 2014 | 24779 views
     

    Singapore Business Review’s 2014 Class of 40 and under

    Singapore Business Review’s 2014 Class of 40 and under

    Meet a summa cumlaude graduate who rises from poverty to become JP Morgan’s head of corporate finance.

    by KRISANA GALLEZO
    12 Jan 2015 | 24303 views

    Find out the 10 most expensive districts to rent an HDB flat in Singapore

    Find out the 10 most expensive districts to rent an HDB flat in Singapore

    Glitzy Bukit Timah is off the list.

    by KRISANA GALLEZO
    19 Dec 2014 | 20393 views
     

    Don’t settle for less: Legendary Hong Kong brings authentic and traditional HK dishes to Singapore

    Don’t settle for less: Legendary Hong Kong brings authentic and traditional HK dishes to Singapore

    The restaurant’s construction cost over a million dollars.

    by KRISANA GALLEZO
    3 Nov 2014 | 8979 views

    Singapore’s hot new restaurants in December

    Singapore’s hot new restaurants in December

    Japanese restos take over Singapore’s sizzling dining scene.

    by KRISANA GALLEZO
    17 Dec 2014 | 7553 views
     

    This food hub in Seah Street brings a throwback experience to dining

    This food hub in Seah Street brings a throwback experience to dining

    It offers an exciting lunch menu which changes every week.

    by KRISANA GALLEZO
    16 Jan 2015 | 2930 views

    Singapore’s first news aggregation app attracts 1 million users in two years

    Singapore’s first news aggregation app attracts 1 million users in two years

    Stay in the loop with news and lifestyle content from SBR and 600 other publishers.

    by KRISANA GALLEZO
    10 Dec 2014 | 2623 views
     

    Go inside the gorgeous new headquarters of Ingredion in Singapore

    Go inside the gorgeous new headquarters of Ingredion in Singapore

    Its state-of-the-art kitchen space is not to be missed.

    by KRISANA GALLEZO
    18 Dec 2014 | 1955 views

    What Singaporean investors can expect from Okinawa’s development

    What Singaporean investors can expect from Okinawa’s development

    A 40% tax cut in setting up business is expected to lure investors.

    by KRISANA GALLEZO
    12 Dec 2014 | 1820 views
     

    This startup created the world’s first bed sensor technology

    This startup created the world’s first bed sensor technology

    No more patients accidentally falling off hospital beds.

    by KRISANA GALLEZO
    14 Jan 2015 | 1776 views

    Jack Wills opens its first store in Singapore

    Jack Wills opens its first store in Singapore

    A 'fun' brand that values the Brit vibe. Put your game face on!

    by KRISANA GALLEZO
    10 Dec 2014 | 1634 views
     

    The future of innovation: What’s next after Facebook and Twitter?

    The future of innovation: What’s next after Facebook and Twitter?

    A video version of Twitter might be under way.

    by KRISANA GALLEZO
    11 Dec 2014 | 1374 views

    What it’s like going into business with your significant other

    What it’s like going into business with your significant other

    A couple who founded an artisanal food outlet, P.Bistro, shares experience.

    by KRISANA GALLEZO
    9 Jan 2015 | 1306 views
     

    Meet INSEAD’s new chairman of the board

    Meet INSEAD’s new chairman of the board

    Find out how Andreas Jacobs plans to bring “business as a force for good”.

    by KRISANA GALLEZO
    14 Jan 2015 | 1246 views

    This could be your best pal when no one’s around to help during an emergency

    This could be your best pal when no one’s around to help during an emergency

    TagBio's ID-Life features accessories with critical info embedded in QR codes.

    by KRISANA GALLEZO
    16 Dec 2014 | 1232 views
     

    Kungfumath wants to revamp boring e-learning portals

    Kungfumath wants to revamp boring e-learning portals

    “Play with numbers” in its literal sense.

    by KRISANA GALLEZO
    5 Dec 2014 | 1057 views

    SFIC Institute's new training hub overhauls carpenters' career image

    SFIC Institute\'s new training hub overhauls carpenters\' career image

    It’s the first carpentry training center in Singapore’s furniture industry.

    by KRISANA GALLEZO
    10 Dec 2014 | 1026 views
     

    Inverted Edge gives spotlight to all independent contemporary fashion designers

    Inverted Edge gives spotlight to all independent contemporary fashion designers

    The homegrown startup has raised US$1.6M total funding in two years.

    by KRISANA GALLEZO
    3 Nov 2014 | 942 views

    FTMSGlobal Academy Singapore launches new weekend MBA

    FTMSGlobal Academy Singapore launches new weekend MBA

    The course fee is below $20,000.

    by KRISANA GALLEZO
    8 Jan 2015 | 698 views
     

    Here’s how migrants can be sure their loved ones back home paid the doctor a visit

    Here’s how migrants can be sure their loved ones back home paid the doctor a visit

    This NRI-focused startup also gives migrants monthly feedback from the doctor.

    by KRISANA GALLEZO
    7 Jan 2015 | 618 views

    ENVision campaign‘s ‘hard truth’ could make you think twice

    ENVision campaign‘s ‘hard truth’ could make you think twice

    Singapore might run out of space for trash by 2035 and more.

    by KRISANA GALLEZO
    15 Dec 2014 | 564 views
     
    close Don't Show Again

    STAY INFORMED! Get our free weekly newsletter